$MATN Mateon Therapeutics (OTCQB: MATN) files a IND with US FDA to Evaluate its Antisense Drug Candidate OT-101 in COVID-19 patients

https://t.co/2qPHGKyaRt

$XYN $REGN $RGNX $BMY $LLY $ABT $PG $AMGN $GSK $GILD

#CoronaVirusCure #CoronaVirusVaccine #HotStocks #Daytrade #Profit